John L. Mattana
Nessuna posizione attualmente
Profilo
John L.
Mattana was a Director of InSite Vision, Inc. from September 1997 to September 23, 2008.
He was an Investment Vice President at New York Life Insurance Company from 1992 to 1997 and was a Director of Venture Capital Investments.
Dr. Mattana was Vice President of Ceptor Corporation from October 1997 to February 2004.
He received an MD degree from the University of Michigan and an MBA from New York University.
Precedenti posizioni note di John L. Mattana
| Società | Posizione | Fine |
|---|---|---|
| INSITE VISION INC. | Direttore/Membro del Consiglio | 23/09/2008 |
CepTor Corp.
 CepTor Corp. Pharmaceuticals: MajorHealth Technology CepTor Corp. develops therapeutic products for neuromuscular and neurodegenerative diseases. It develops proprietary, receptor mediated drug-targeting platform, the inhibition of the protease calpain and specific delivery of other therapeutic compounds. The company's product MYODUR is into phase I/II clinical trials for muscular dystrophy. CepTor was founded in 1986 and is located in Hunt Valley, MD. | Corporate Officer/Principal | 01/02/2004 |
New York Life Insurance Co.
 New York Life Insurance Co. Life/Health InsuranceFinance New York Life Insurance Co. engages in the provision of insurance products and services. It offers life insurance, retirement income, long term care, investments, and premier services. The company was founded on April 12, 1845 and is headquartered in New York, NY. | Direttore degli Investimenti | 01/01/1997 |
Formazione di John L. Mattana
| New York University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
InSite Vision, Inc.
 InSite Vision, Inc. Pharmaceuticals: MajorHealth Technology InSite Vision Inc. develops and markets ophthalmic pharmaceutical products that designs to treat a range of common eye problems, including ocular infection, pain and inflammation in ocular surgery, and glaucoma. Its products include AzaSite, Besivance, AzaSite Plus, DexaSite, AzaSite Xtra, and ISV-10 and 303. The company was founded by Merwin Jerry Hansen in 1986 and is headquartered in Alameda, CA. | Health Technology |
New York Life Insurance Co.
New York Life Insurance Co. Life/Health InsuranceFinance New York Life Insurance Co. engages in the provision of insurance products and services. It offers life insurance, retirement income, long term care, investments, and premier services. The company was founded on April 12, 1845 and is headquartered in New York, NY. | Finance |
CepTor Corp.
CepTor Corp. Pharmaceuticals: MajorHealth Technology CepTor Corp. develops therapeutic products for neuromuscular and neurodegenerative diseases. It develops proprietary, receptor mediated drug-targeting platform, the inhibition of the protease calpain and specific delivery of other therapeutic compounds. The company's product MYODUR is into phase I/II clinical trials for muscular dystrophy. CepTor was founded in 1986 and is located in Hunt Valley, MD. | Health Technology |
- Borsa valori
- Insiders
- John L. Mattana
